CVM Return on Tangible Equity | CEL-SCI CORPORATION

CEL-SCI CORPORATION (CVM) Return on Tangible Equity

2026-06-30: Return Tang Equity -208.56%.
2026-03-31: Return Tang Equity -333.77%.
2025-12-31: Return Tang Equity -215.70%.
2025-09-30: Return Tang Equity -160.45%.

Complete source-backed return tang equity history.

Available history: 2009-09-30 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	-208.56%
2026-03-31	-333.77%
2025-12-31	-215.70%
2025-09-30	-160.45%
2025-06-30	-368.70%
2025-03-31	-338.72%
2024-12-31	-244.48%
2024-09-30	-211.95%
2024-06-30	-344.74%
2024-03-31	-213.28%
2023-12-31	-250.54%
2023-09-30	-248.64%
2023-06-30	-226.10%
2023-03-31	-171.84%
2022-12-31	-135.55%
2022-09-30	-114.87%
2022-06-30	-94.64%
2022-03-31	-79.63%
2021-12-31	-72.79%
2021-09-30	-64.63%
2021-06-30	-56.35%
2021-03-31	-120.09%
2020-12-31	-114.46%
2020-09-30	-155.84%
2020-06-30	-144.46%
2020-03-31	-228.07%
2019-12-31	-334.50%
2019-09-30	-459.03%
2019-06-30	-3686.50%
2019-03-31	-3670.39%
2018-12-31	-994.04%
2018-09-30	12379.49%
2018-06-30	1481.13%
2018-03-31	623.37%
2017-12-31	476.78%
2017-09-30	403.45%
2017-06-30	190.03%
2017-03-31	299.05%
2016-12-31	-246.85%
2016-09-30	1230.28%
2016-06-30	499.87%
2016-03-31	646.88%
2015-12-31	-753.60%
2015-09-30	686.11%
2015-06-30	-883.98%
2015-03-31	-85526.85%
2014-12-31	-267.93%
2014-09-30	-270.42%
2014-06-30	-148.56%
2014-03-31	-339.02%
2013-12-31	-75.67%
2013-09-30	-143.70%
2013-06-30	-134.50%
2013-03-31	-57.36%
2012-12-31	-126.14%
2012-09-30	-232.98%
2012-06-30	-176.82%
2012-03-31	-299.01%
2011-12-31	-298.77%
2011-09-30	-296.75%
2011-06-30	-351.16%

Annual Return Tang Equity

Date	Return Tang Equity
2025-09-30	-160.45%
2024-09-30	-211.95%
2023-09-30	-248.64%
2022-09-30	-114.87%
2021-09-30	-64.63%
2020-09-30	-155.83%
2019-09-30	-459.03%
2018-09-30	12379.49%
2017-09-30	403.45%
2016-09-30	1230.28%
2015-09-30	686.11%
2014-09-30	-270.42%
2013-09-30	-143.70%
2012-09-30	-232.98%
2011-09-30	-296.75%
2010-09-30	38.12%
2009-09-30	-462.75%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Quince Therapeutics, Inc. (QNCX)	United States	$0.031B
aTYR PHARMA INC (ATYR)	United States	$0.033B	-0.98
Estrella Immunopharma, Inc. (ESLA)	United States	$0.020B
Jasper Therapeutics, Inc. (JSPR)	United States	$0.020B	-0.37
Scilex Holding Co (SCLX)	United States	$0.042B	-0.14
Metagenomi Therapeutics, Inc. (MGX)	United States	$0.044B	-0.48
BioCardia, Inc. (BCDA)	United States	$0.016B
DYADIC INTERNATIONAL INC (DYAI)	United States	$0.016B
Passage BIO, Inc. (PASG)	United States	$0.015B	-0.43
LeonaBio, Inc. (LONA)	United States	$0.047B	-0.61